Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial

被引:7
作者
Slagboom, Ton [1 ]
Toelg, Ralph [2 ]
Witzenbichler, Bernhard [3 ]
Haude, Michael [4 ]
Masotti, Monica [5 ]
Salmeron, Rafael Ruiz [6 ]
Witkowski, Adam Ryszard [7 ]
Uematus, Masaaki [8 ]
Takahashi, Akihiko [9 ]
Waksman, Ron [10 ]
Satio, Shigeru [11 ]
机构
[1] OLVG, Cardiol Unit, Amsterdam, Netherlands
[2] Segeberger Kliniken, Herzzentrum, Bad Segeberg, Germany
[3] Helios Amper Klinikum, Dept Cardiol & Pneumol, Dachau, Germany
[4] Stadt Kliniken Neuss, Lukaskrankenhaus Med Klin I, Neuss, Germany
[5] Hosp Clin Barcelona, Dept Cardiol, Barcelona, Spain
[6] Hosp Univ Virgen Macarena, Haemodynam Unit, Seville, Spain
[7] Natl Inst Cardiol, Warsaw, Poland
[8] Kansai Rosai Hosp, Cardiovasc Ctr, Amagasaki, Japan
[9] Sakurakai Takahashi Hosp, Kobe, Japan
[10] MedStar Hlth Res Inst, Washington, DC USA
[11] Okinawa Tokushukai Shonan Kamakura Gen Hosp, Kamakura, Japan
关键词
D O I
10.4244/EIJ-D-22-00526
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1197 / +
页数:8
相关论文
共 5 条
[1]   Clinical Outcomes Following Implantation of Thin-Strut, Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY Stents Final 5-Year Results of the EVOLVE II Randomized Trial [J].
Kereiakes, Dean J. ;
Windecker, Stephan ;
Jobe, R. Lee ;
Mehta, Shamir R. ;
Sarembock, Ian J. ;
Feldman, Robert L. ;
Stein, Bernardo ;
Dubois, Christophe ;
Grady, Timothy ;
Saito, Shigeru ;
Kimura, Takeshi ;
Underwood, Paul ;
Allocco, Dominic J. ;
Meredith, Ian T. .
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (09)
[2]   Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents - Results from the TAXUS-IV trial [J].
Pinto, Duane S. ;
Stone, Gregg W. ;
Ellis, Stephen G. ;
Cox, David A. ;
Hermiller, James ;
O'Shaughnessy, Charles ;
Mann, J. Tift ;
Mehran, Roxana ;
Na, Yingbo ;
Turco, Mark ;
Caputo, Ronald ;
Popma, Jeffrey J. ;
Cutlip, Donald E. ;
Russell, Mary E. ;
Cohen, David J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (01) :32-36
[3]   BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12 months [J].
Saito, Shigeru ;
Toelg, Ralph ;
Witzenbichler, Bernhard ;
Haude, Michael ;
Masotti, Monica ;
Salmeron, Ruiz ;
Witkowski, Adam ;
Uematsu, Masaaki ;
Takahashi, Akihiko ;
Waksman, Ron ;
Slagboom, Ton .
EUROINTERVENTION, 2019, 15 (11) :E1006-+
[4]   Individual patient data analysis of the BIOFLOW study program comparing safety and efficacy of a bioresorbable polymer sirolimus eluting stent to a durable polymer everolimus eluting stent [J].
Toelg, Ralph ;
Slagboom, Ton ;
Waltenberger, Johannes ;
Lefevre, Thierry ;
Saito, Shigeru ;
Kandzari, David E. ;
Koolen, Jacques ;
Richardt, Gert .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 98 (05) :848-856
[5]   Long-term clinical outcomes after bioresorbable and permanent polymer drug-eluting stent implantation: final five-year results of the CENTURY II randomised clinical trial [J].
Wijns, William ;
Valdes-Chavarri, Mariano ;
Richardt, Gert ;
Moreno, Raul ;
Iniguez-Romo, Andres ;
Barbato, Emanuele ;
Carrie, Didier ;
Ando, Kenji ;
Merkely, Bela ;
Kornowski, Ran ;
Eltchaninoff, Helene ;
Stojkovic, Sinisa ;
Saito, Shigeru .
EUROINTERVENTION, 2018, 14 (03) :343-351